Micron Stock Falls but Analysts Are Bullish Despite Gross Margin ‘Fly in the Ointment’



Key Takeaways

  • Micron stock slid Friday following the company’s fiscal second-quarter results.
  • Several analysts maintained bullish ratings, however, based in part on an improving outlook for its DRAM chips.
  • Investors may have reacted to Micron’s gross margin projections, which one analyst called a “fly in the ointment.”

Shares of Micron Technology (MU) turned lower Friday after the company’s fiscal second-quarter results a day earlier, but analysts have remained bullish on the memory chip company. 

Micron “has established technology leadership in [high-bandwith memory],” UBS analysts said after the results, and its DRAM chip business “should operate with more sustained supply/demand dynamics as long as AI continues to grow.” The bank maintained its “buy” rating and $130 price target. 

Despite initially rising after the results were released, Micron shares dropped around 8% intraday Friday. The chipmaker’s revenue and profit forecast came in above Wall Street’s expectations, but UBS said the company’s commentary on gross margins was “a bit of a fly in the ointment.” 

Citi analysts also reiterated a “buy” rating but trimmed their price target from $150 to $120 “given Micron’s persistent gross margin issues.” The bank raised its full-year sales and earnings per share estimates, driven by expected improvements in the DRAM market. Meanwhile, Wedbush raised its price target to $130 from $125, and Bank of America stood pat at $110.



Source link

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles